Baclofen is known to produce auditory hallucination, a auditory effect. Auditory hallucination is the perception of sounds that have no external source — hearing music, voices, environmental noises, or abstract sonic phenomena that exist entirely within the mind. These range from faint, ambiguous whispers at the edge of perception to fully formed, complex musical compositions or conversational speech that can feel completely real and externally sourced.
From a first-person perspective, auditory hallucinations manifest as sounds that feel genuinely external — as though they originate from somewhere in the physical environment — despite having no corresponding source. One may hear faint music playing from another room, indistinct conversational murmuring, environmental sounds like running water or wind, or entirely novel sonic phenomena such as buzzing, chiming, or crystalline tones. At higher intensities, full musical compositions may be perceived with remarkable complexity and fidelity, sometimes in genres or styles the listener has never heard before. Voices may speak coherent sentences, sometimes addressing the user directly, though insight is usually maintained that these are drug-induced.
At threshold levels, auditory hallucinations present as vague, ambiguous sounds — one might question whether a faint sound was real or imagined. At light to moderate intensities, the hallucinations become more distinct: identifiable snippets of music, recognizable whispered words, or phantom environmental sounds like doorbells or phone notifications. At strong doses, fully formed auditory experiences emerge — entire songs with lyrics, complex conversations, or rich environmental soundscapes that are indistinguishable from reality until one actively questions their origin. At overwhelming levels, the hallucinated audio can completely dominate the perceptual field, making it difficult to distinguish real from imagined sound.
Musical hallucinations involve hearing melodies, harmonies, or complete compositions, often novel and not drawn from memory.Verbal hallucinations consist of hearing words or sentences — these may be fragments, gibberish, or coherent speech.Environmental hallucinations replicate familiar ambient sounds (rain, traffic, appliances).Abstract sonic hallucinations produce sounds without clear real-world analogues — geometric buzzing, fractal tones, or sounds that seem to have visual or spatial properties. Auditory hallucinations can beopen-eye (perceived as external) orclosed-eye (perceived as internal, mind's-ear phenomena).
Auditory hallucinations arise from spontaneous activation of auditory cortical areas in the absence of corresponding external stimuli. Serotonergic psychedelics facilitate this through 5-HT2A agonism, which increases spontaneous neural firing in auditory association cortex and disrupts the brain's ability to distinguish internally generated signals from external input. Dissociatives produce auditory hallucinations through NMDA antagonism, which impairs sensory gating mechanisms and can lead to disinhibited firing in temporal lobe auditory regions. Deliriants such as diphenhydramine produce particularly vivid and realistic auditory hallucinations through muscarinic acetylcholine receptor antagonism, which profoundly disrupts the neurotransmitter systems involved in reality testing.
Auditory hallucinations occur across many substance classes but with qualitatively different characters. Psychedelics (LSD, psilocybin, DMT) tend to produce musical and abstract auditory hallucinations, often pleasant and complex.Dissociatives (ketamine, DXM, PCP) can generate immersive sonic environments, particularly during dissociative holes.Deliriants (diphenhydramine, datura) produce the most realistic and often disturbing auditory hallucinations — convincing phantom conversations and environmental sounds that are difficult to distinguish from reality.Cannabis at high doses, particularly edibles, can produce mild auditory hallucinations.Stimulant psychosis from prolonged use of amphetamines or cocaine can generate persecutory auditory hallucinations.
While psychedelic auditory hallucinations are generally benign and often enjoyable, deliriant-induced auditory hallucinations deserve serious caution — they can be indistinguishable from reality and may provoke dangerous behavioral responses. Stimulant-induced auditory hallucinations (especially persecutory voices) are a sign of psychosis and indicate a medical emergency requiring cessation of use and professional help. Individuals with a personal or family history of schizophrenia or psychotic disorders should exercise extreme caution with any substance that produces auditory hallucinations, as these effects may trigger or exacerbate underlying conditions. If hallucinated voices become commanding or frightening, this is a sign to seek immediate support.
Auditory hallucination can manifest at varying intensities depending on the dose of Baclofen and individual sensitivity. The following levels describe the typical progression of this effect.
Vague, ambiguous sounds at the edge of perception — faint whispers, phantom notification sounds, or barely audible music that one cannot be sure is real.
Identifiable sounds with no source — distinct musical snippets, recognizable words or phrases, phantom environmental sounds like a ringing phone.
Clear and detailed auditory hallucinations — full melodies, conversational fragments, or rich environmental soundscapes; one can usually still distinguish them from reality.
Complex, vivid auditory experiences — entire songs with lyrics, coherent conversations, or immersive sonic environments that are difficult to distinguish from real sounds.
Complete auditory hallucination dominance — the hallucinated soundscape is indistinguishable from reality; real and imagined sounds merge into a single perceptual stream.
Baclofen produces its effects by activating the GABAB receptor, similar to the drug phenibut which also activates this receptor and shares some of its effects. Baclofen is postulated to block mono-and-polysynaptic reflexes by acting as an inhibitory ligand, inhibiting the release of excitatory neurotransmitters.
Similarly to phenibut (β-phenyl-GABA), as well as pregabalin (β-isobutyl-GABA), which are close analogues of baclofen, baclofen (β-(4-chlorophenyl)-GABA) has been found to block α2δ subunit-containing voltage-gated calcium channels (VGCCs). However, it is weaker relative to phenibut in this action (Ki = 23 and 39 μM for R- and S-phenibut and 156 μM for baclofen).
Moreover, baclofen is in the range of 100-fold more potent by weight as an agonist of the GABAB receptor in comparison to phenibut, and in accordance, is used at far lower relative dosages. As such, the actions of baclofen on α2δ subunit-containing VGCCs are likely not clinically-relevant.
The drug is rapidly absorbed after oral administration and is widely distributed throughout the body. Biotransformation is low: the drug is predominantly excreted unchanged by the kidneys.
Baclofen is often compared to phenibut, but more "messy", less euphoric, anxiolytic, and causing a stronger dizziness.
low toxicity relative to dose. However, it is lethal when mixed with depressants like alcohol, benzodiazepines or opioids]].
It is strongly recommended that one use harm reduction practices when using this substance. -moderately physically and psychologically addictive. Discontinuation of baclofen can be associated with a withdrawal syndrome which resembles benzodiazepine withdrawal and alcohol withdrawal. Withdrawal symptoms are more likely if baclofen is used for long periods of time (more than a couple of weeks) and can occur from low or high doses.
The severity of baclofen withdrawal depends on the rate at which it is discontinued. Abrupt withdrawal is more likely to result in severe withdrawal symptoms. Acute withdrawal symptoms can be stopped by recommencing baclofen.
Tolerance will develop to the sedative-within a couple of days of continuous use. After cessation,7 - 14 days.
Withdrawal symptoms or rebound symptoms may occur after ceasing usage abruptly following a few weeks or longer of steady dosing and may necessitate a gradual dose reduction. Withdrawal symptoms may include auditory hallucinations, visual hallucinations, tactile hallucinations, delusions, confusion, delirium, disorientation, fluctuation of consciousness, insomnia, dizziness, nausea, inattention, memory impairments, perceptual disturbances, itchiness, anxiety, depersonalization, hypertonia, hyperthermia, psychosis, mania, mood disturbances, tachycardia, seizures, tremors, autonomic dysfunction, hyperpyrexia (fever), extreme muscle rigidity resembling neuroleptic malignant syndrome and rebound spasticity.
Baclofen produces cross-tolerance with Cross-all GABAgenic depressants, meaning that after its consumption, depressants will have a reduced effect. -Depressants** (1,4-Butanediol, 2M2B,Alcohol,Benzodiazepines,Barbiturates,GHB/GBL,Methaqualone,Opioids) - This combination can result in dangerous or even fatal levels of respiratory depression. These substances potentiate the muscle relaxation, sedation and amnesia caused by one another and can lead to unexpected loss of consciousness at high doses. There is also an increased risk of vomiting during unconsciousness and death from the resulting suffocation. If this occurs, users should attempt to fall asleep in the recovery position or have a friend move them into it.
Dissociatives** - This combination can result in an increased risk of vomiting during unconsciousness and dying from the resulting suffocation. If a sudden loss of consciousness occurs, users should attempt to fall asleep in the recovery position or have a friend move them into it.
Stimulants** - It is dangerous to combine baclofen with stimulants due to the risk of excessive intoxication. Stimulants mask the sedative effect of baclofen, which is the main factor most people consider when determining their level of intoxication. Once the stimulant wears off, the effects of baclofen will be significantly increased, leading to intensified disinhibition as well as other effects. If combined, one should strictly limit themselves to only dosing a certain amount of baclofen per hour. This combination can also potentially result in severe dehydration if hydration is not monitored.
Germany: Baclofen is a prescription medicine, according to Anlage 1 AMVV.
Russia: Baclofen is available through a prescription. Storing and transporting baclofen without a prescription can be considered a crime and result in criminal prosecution.
Sweden: Baclofen is available through a prescription.
Turkey: Baclofen is available at pharmacies without prescription.
United States: Baclofen is not a scheduled substance, but may only be sold with a prescription.
Responsible use
Gabapentinoid
GABA
Phenibut
Pregabalin
Baclofen (Wikipedia)
Baclofen (Erowid Vault)
Baclofen (Isomer Design)
Baclofen can be administered via oral. The route of administration can influence both the onset and intensity of auditory hallucination.
The intensity of auditory hallucination depends heavily on the dose of Baclofen. Effects like auditory hallucination are typically reported at common to strong doses. Below is the full dosage chart for Baclofen.
Warning
Realistic auditory hallucinations, especially from deliriants or stimulant psychosis, can be indistinguishable from reality and may prompt dangerous behavior. Hearing commanding or persecutory voices is a sign of acute psychosis requiring immediate medical attention. Individuals with a history of psychotic disorders should avoid substances that produce this effect.
Yes. Auditory hallucination is a documented auditory effect of Baclofen. Auditory hallucination is the perception of sounds that have no external source — hearing music, voices, environmental noises, or abstract sonic phenomena that exist entirely within the mind. These range from faint, ambiguous whispers at the edge of perception to fully formed, complex musical compositions or conversational speech that can feel completely real and externally sourced.
Effects like auditory hallucination are typically reported at common doses and above. A common oral dose of Baclofen is 20–50 mg.
Other substances documented to produce auditory hallucination include Diphenhydramine, Datura, Dextromethorphan, Methamphetamine, Ibogaine, and 35 more.
